v3.25.4
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Series A
Series B
Series D
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Temporary equity, beginning balance (in shares) at Dec. 31, 2022 118,129,000            
Temporary equity, beginning balance at Dec. 31, 2022 $ 448,777            
Increase (Decrease) in Temporary Equity [Roll Forward]              
Issuance of Series A redeemable convertible preferred stock upon exercise of warrants / Automatic cashless exercise of all outstanding Series B redeemable convertible preferred stock warrants / Cashless exercise of all outstanding Series D redeemable convertible preferred stock warrants (in shares)   90,000          
Issuance of Series A redeemable convertible preferred stock upon exercise of warrants / Automatic cashless exercise of all outstanding Series B redeemable convertible preferred stock warrants / Cashless exercise of all outstanding Series D redeemable convertible preferred stock warrants   $ 257          
Temporary equity, ending balance (in shares) at Dec. 31, 2023 118,219,000            
Temporary equity, ending balance at Dec. 31, 2023 $ 449,034            
Beginning balance (in shares) at Dec. 31, 2022         6,977,000    
Beginning balance at Dec. 31, 2022 (293,172)       $ 6 $ 36,140 $ (329,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)         411,000    
Issuance of common stock upon exercise of stock options 1,755       $ 1 1,754  
Share-based compensation expense 8,816         8,816  
Net loss and comprehensive loss (67,511)           (67,511)
Net loss and comprehensive loss (67,511)           (67,511)
Ending balance (in shares) at Dec. 31, 2023         7,388,000    
Ending balance at Dec. 31, 2023 $ (350,112)       $ 7 46,710 (396,829)
Temporary equity, ending balance (in shares) at Dec. 31, 2024 118,219,000 12,005,000 19,445,000 21,230,000      
Temporary equity, ending balance at Dec. 31, 2024 $ 449,034 $ 6,547 $ 22,932 $ 106,704      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)         769,000    
Issuance of common stock upon exercise of stock options 3,329       $ 1 3,328  
Share-based compensation expense 9,517         9,517  
Net loss and comprehensive loss (47,137)           (47,137)
Net loss and comprehensive loss $ (47,137)           (47,137)
Ending balance (in shares) at Dec. 31, 2024 8,157,000       8,157,000    
Ending balance at Dec. 31, 2024 $ (384,403)       $ 8 59,555 (443,966)
Increase (Decrease) in Temporary Equity [Roll Forward]              
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) (118,446,000)            
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering $ (452,112)            
Issuance of Series A redeemable convertible preferred stock upon exercise of warrants / Automatic cashless exercise of all outstanding Series B redeemable convertible preferred stock warrants / Cashless exercise of all outstanding Series D redeemable convertible preferred stock warrants (in shares)     92,000 135,000      
Issuance of Series A redeemable convertible preferred stock upon exercise of warrants / Automatic cashless exercise of all outstanding Series B redeemable convertible preferred stock warrants / Cashless exercise of all outstanding Series D redeemable convertible preferred stock warrants     $ 493 $ 2,585      
Temporary equity, ending balance (in shares) at Dec. 31, 2025 0            
Temporary equity, ending balance at Dec. 31, 2025 $ 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares) 1,596,000       1,614,000    
Issuance of common stock upon exercise of stock options $ 9,727       $ 2 9,725  
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and offering costs (in shares)         9,085,000    
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and offering costs 151,600       $ 9 151,591  
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)         39,482,000    
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 452,112       $ 39 452,073  
Issuance of common stock upon settlement of restricted stock units, net (in shares)         56,000    
Issuance of common stock upon settlement of restricted stock units, net (359)         (359)  
Cashless exercise of all outstanding common stock warrants (in shares)         35,000    
Cashless exercise of all outstanding common stock warrants 642         642  
Share-based compensation expense 13,139         13,139  
Net loss and comprehensive loss (12,778)           (12,778)
Net loss and comprehensive loss $ (12,778)           (12,778)
Ending balance (in shares) at Dec. 31, 2025 58,429,000       58,429,000    
Ending balance at Dec. 31, 2025 $ 229,680       $ 58 $ 686,366 $ (456,744)